Latest News for: dose

Edit

The new malaria vaccine helps in Africa but faces dosing test

ABC News 15 Jul 2026
A recently introduced malaria vaccine is helping reduce severe illness in children across Africa ... .
Edit

FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease

Image The Eagle-Tribune 14 Jul 2026
LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) ... .
Edit

ADDF Statement: FDA Approval of Subcutaneous Starting Dose for Leqembi Advances Alzheimer's Care Toward Combination ...

Image Morgan Citizen 14 Jul 2026
Initiation of treatment with subcutaneous administration opens the door to fully at-home dosing, similar to injectable diabetes and GLP-1 weight loss therapies ... .
Edit

Domp� Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

Business Wire 14 Jul 2026
MILAN & SAN MATEO, Calif.--(BUSINESS WIRE)--Domp� advances cenegermin-bkbj into Phase 3 for NAION, a rapid vision-loss condition with no FDA-approved treatment options ... .
Edit

Assessment of Platelet Function Between Low-Dose Prasugrel and Clopidogrel in Patients Undergoing Neuroendovascular Treatment (Sysmex Corporation)

Public Technologies 14 Jul 2026
) Presented by.. Miyu Kitagami1, Kenji Shoda2, Tasuku Sakayori1, Yoshihiko Ueno3, Ayumu Kanbe3, Aki Oka3, ... Academic conference.. ISTH 2026 Congress Presentation Date.. July 13, 2026 ... Newsroom. Attachments Original document Permalink.
Edit

HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction

PR Newswire 14 Jul 2026
The Phase 1 results reported by BioAge have positioned BGE-102 as a potential best-in-class NLRP3 inhibitor, with profound hsCRP reductions on a well-tolerated, once-daily oral dose.
Edit

Rayence Launches 'SHINE,' a Next-Generation X-ray Image Processing Technology for Low Dose Imaging

PR Newswire 14 Jul 2026
This helps deliver sharp, clear images even under low- dose exposure conditions ... SHINE is designed to maintain image sharpness even under low-dose X-ray imaging conditions, empowering clinical staff to make efficient and accurate diagnostic decisions.
Edit

WHO issues updated dosing guidance for antiretroviral medicines used in newborns, infants and children

World Health Organization 14 Jul 2026
The guidance.sets out harmonized weight-band dosing approaches meant to simplify prescribing, dispensing and programme implementation, while maintaining appropriate drug exposure across age ...
Edit

WHO issues updated dosing guidance for antiretroviral medicines used in newborns, infants and children (WHO - World Health Organization)

Public Technologies 14 Jul 2026
sets out harmonized weight-band dosing approaches meant to simplify prescribing, dispensing and programme implementation, while maintaining appropriate drug exposure across age groups; updates ...
×